Relay Medical Announces Results of Special Meeting; Name Change Approved
Toronto, Ontario--(Newsfile Corp. - September 20, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the...
Month: September 2021
Revenue Cycle Management Market worth $67.8 billion by 2026 – Exclusive Report by MarketsandMarkets™
CHICAGO, Sept. 20, 2021 /PRNewswire/ -- According to the new market research report "Revenue Cycle Management/RCM Market by Product &...
Introducing The Lyric™ Therapeutic Massager, An Evolution In Self-Care
SANTA MONICA, Calif., Sept. 20, 2021 /PRNewswire/ -- Today marks an evolution in self-care with the launch of the new Wi-Fi-enabled...
CDC and Bark Technologies Collaborate on First-Ever Study Linking Past Online Behavior in Youth to Future Events of Suicide and Self-Harm
ATLANTA, Sept. 20, 2021 /PRNewswire/ -- Together with The Centers for Disease Control and Prevention's National Center for Injury Prevention and...
Surgical Theater 360XR Visualization Utilized in Successful Separation of Extremely Rare Conjoined Twins in Israel
LOS ANGELES, Sept. 20, 2021 /PRNewswire/ -- Surgery itself is very daunting, but a surgery that has only been performed a...
Love Hemp Group PLC Announces Change of Registered Office
LONDON, UK / ACCESSWIRE / September 20, 2021 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), one of the UK's leading CBD...
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
– Live fireside chat with Paula Brown Stafford, President and Chief Executive Officer of Novan on Tuesday, September 28 at...
Simulated Environment Concepts, Inc. Announces Acquisition of Nitro Holdings LLC
NASHVILLE, TN, Sept. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Simulated Environment Concepts, Inc. (OTC-PINK:SMEV) is proud to announce...
Humacyte Announces Issuance of Three Additional U.S. Patents Covering its Proprietary Universally Implantable Bioengineered Human Tissue Platform
Patent estate also expanded by the issuance of 23 additional patents in international marketsHumacyte now owns or licenses 119 patents...
Arecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetes
Arecor Therapeutics plc(“Arecor”, the “Company” or the “Group”) ARECOR ANNOUNCES POSITIVE HEADLINE RESULTS FROM FIRST PHASE I CLINICAL TRIAL OF...
CENTR Brands Corp. Announces Q1’22 473% Record Sales Increase
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company")...
Tanner Pharma Group Announces New EVP of Technical Operations
CHARLOTTE, N.C.--(BUSINESS WIRE)--Tanner Pharma Group (“Tanner”), a global pharma-solutions provider, today announced the hiring of Lee Holmes as Executive Vice...
NextGen Healthcare Appoints David Sides President and Chief Executive Officer
Sides Brings Extensive Experience in Healthcare Software and Technology, and Proven Record Growing, Scaling and Diversifying Premier Global Healthcare Companies...
Marpai to Host Inaugural SMART Health Summit
Dr. Daniel Kraft, Chair of Medicine at Singularity University, Founder and Chair of Exponential Medicine and Six Time TED Speaker...
Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc.
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
2022 Commercial Fleet & MRO Forecast Now Available From Aviation Week Network
Over the Next Decade, Optimistic Viewpoint of Commercial Aviation’s Growth Out of the Pandemic; Airbus to Extend Lead in Narrowbody...
Defence Therapeutics Successfully Engineered and Tested a Novel Intranasal COVID-19 Vaccine Formulation in Animals
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
Mauna Kea Technologies Announces a Capital Increase of Approximately €12.5 Million Reserved for Two Investors
This transaction by issuance of Units allows the Company to secure its financing until the end of the third quarter...
Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for...
Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19
SHANGHAI, China, Sept. 19, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated...